Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
PFIZER On Other Exchanges
Symbol
Exchange
PFIZER is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

pfizer limited (PFIZER) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PFIZER LIMITED (PFIZER)

Related News

No related news articles were found.

pfizer limited (PFIZER) Related Businessweek News

No Related Businessweek News Found

pfizer limited (PFIZER) Details

Pfizer Limited engages in the manufacture, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers prescription medicines and consumer healthcare products in the areas of anti-allergic, anti-diabetic, antihistamine, anti-infectives, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, GI, multivitamins, neurology, pain/fever/inflammation, pain/inflammation, pediatrics, pediatrics, psychiatry, respiratory, urology, and vitamin/minerals. It sells its products through independent distributors primarily in India. The company was incorporated in 1950 and is headquartered in Mumbai, India. Pfizer Limited is a subsidiary of Pfizer East India BV.

2,417 Employees
Last Reported Date: 10/9/14
Founded in 1950

pfizer limited (PFIZER) Top Compensated Officers

Managing Director, Director, Member of Nomina...
Total Annual Compensation: 30.3M
Chief Financial Officer, Head of Finance & Di...
Total Annual Compensation: 12.7M
Executive Director of Technical Operations, W...
Total Annual Compensation: 10.6M
Compensation as of Fiscal Year 2014.

pfizer limited (PFIZER) Key Developments

Pfizer To Acquire Swedish Orphan Biovitrum

As per reports Swedish Orphan Biovitrum AB (OM:SOBI) had received an offer to be acquired earlier this week. It has been revealed that the preliminary offer had come from Pfizer Inc. (NYSE:PFE). The price that Pfizer has offered could not be learned. Spokesmen for both Sobi and Pfizer declined to comment. Pfizer Chief Executive Officer Ian Read said on Tuesday during an earnings call that he was open to deals and was "agnostic" about the size of acquisitions.

Mylan Inc. and Mylan Pharmaceuticals Inc. Enters into Patent Litigation Settlement with Pfizer Inc., Pfizer Limited and Pfizer Ireland Pharmaceuticals

Mylan Inc. and Mylan Pharmaceuticals Inc. have entered into a settlement and license agreement with Pfizer Inc., Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's abbreviated new drug application, or ANDA, filed with the FDA for Sildenafil Citrate tablets 25mg, 50mg, and 100mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the US Department of Justice and the Federal Trade Commission.

Pfizer Ltd. Wins GBP 220.9 Million Multiple Awardees Contract

Pfizer Ltd. won a GBP 220.9 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of proprietary pharmaceuticals.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ:IN 2,087.95 INR 0.00

PFIZER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,940 INR 0.00
ARIAD Pharmaceuticals Inc $9.15 USD +0.48
Array BioPharma Inc $6.32 USD +0.07
Merit Medical Systems Inc $19.88 USD +0.47
Sanofi India Ltd 3,320 INR 0.00
View Industry Companies
 

Industry Analysis

PFIZER

Industry Average

Valuation PFIZER Industry Range
Price/Earnings 76.6x
Price/Sales 5.7x
Price/Book 9.0x
Price/Cash Flow 44.8x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER LIMITED, please visit www.pfizerindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.